NetSol Technologies (NASDAQ:NTWK – Get Free Report)‘s stock had its “hold (c)” rating restated by investment analysts at Weiss Ratings in a note issued to investors on Tuesday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded NetSol Technologies to a “strong-buy” rating in a research report on Saturday, October 11th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.
Read Our Latest Stock Analysis on NTWK
NetSol Technologies Price Performance
NetSol Technologies (NASDAQ:NTWK – Get Free Report) last released its earnings results on Monday, September 29th. The software maker reported $0.22 earnings per share (EPS) for the quarter. NetSol Technologies had a return on equity of 7.40% and a net margin of 4.46%.The firm had revenue of $18.40 million for the quarter.
Institutional Trading of NetSol Technologies
An institutional investor recently bought a new position in NetSol Technologies stock. PFG Investments LLC purchased a new stake in shares of NetSol Technologies Inc. (NASDAQ:NTWK – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 25,000 shares of the software maker’s stock, valued at approximately $78,000. PFG Investments LLC owned approximately 0.21% of NetSol Technologies at the end of the most recent quarter. 16.02% of the stock is currently owned by institutional investors.
About NetSol Technologies
NetSol Technologies, Inc designs, develops, markets, and exports enterprise software solutions to the automobile financing and leasing, banking, and financial services industries worldwide. The company offers NFS Ascent, a suite of financial applications for businesses in the finance and leasing industry.
Further Reading
- Five stocks we like better than NetSol Technologies
- Investing in the High PE Growth Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Business Services Stocks Investing
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Start Investing in Real Estate
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for NetSol Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NetSol Technologies and related companies with MarketBeat.com's FREE daily email newsletter.